AI Tackles Aging: OpenAI’s Leap into Longevity Science
Can AI help us live longer? OpenAI thinks so, and its latest project might just reshape biology as we know it.
OpenAI has ventured into biology with GPT-4b micro, an AI model designed to engineer proteins for longevity science. Collaborating with Retro Biosciences, the model reimagined Yamanaka factors, proteins that turn ordinary cells into stem cells—making them 50 times more effective in some cases.
While traditional methods can only test a handful of protein variations, AI’s ability to analyze vast possibilities accelerated progress. These advancements promise breakthroughs in creating stem cells for rejuvenating tissues and building organs.
However, the model’s opaque decision-making process raises questions about its inner workings and ethical concerns regarding its applications. If AI can crack the code for aging, how do we balance innovation with ethics in shaping our future?
Read the full article on MIT Technology Review.
----
💡 If you enjoyed this content, be sure to download my new app for a unique experience beyond your traditional newsletter.
This is one of many short posts I share daily on my app, and you can have real-time insights, recommendations and conversations with my digital twin via text, audio or video in 28 languages! Go to my PWA at app.thedigitalspeaker.com and sign up to take our connection to the next level! 🚀